Tag: our research

Dr Martina Finetti tells us about her background and her research into rare childhood brain tumours.

We have recently announced we will funding a study that looks at whether a therapy called Acceptance and Commitment Therapy (ACT) can be adapted to help treat young brain tumour survivors.

The Brain Tumour Charity are excited to announce that we will be funding a study exploring whether a psychological therapy called Acceptance and Commitment Therapy (ACT) can be adapted to help treat young brain tumour survivors.

A report published today into the use of medicinal cannabis for problems such as nausea caused by chemotherapy says patients have had their expectations raised unfairly by a change in the law last year

Our funded research has created a tool to help clinicians predict meningioma recurrence

Scottish scientist set to receive over £6 million from Cancer Research UK and The Brain Tumour Charity to find new ways to treat glioblastoma, one of the hardest types of cancer to treat.

Thanks to the support of our community, we’re pledging more than £3.7m to UK and international teams working towards our twin goals: doubling brain tumour survival and halving the harm caused by the disease

A research team from Germany has used artificial intelligence to improve the assessment of treatment response in brain tumours

As part of our commitment to increasing survival and halving the harm of brain tumours, we have committed over £1 million to transformative research

Thanks to your continued support and fundraising, we’re delighted to announce that we’ve been able to award over £3.8 million to five new exciting research initiatives across the globe

Dr Thomas Ward, part of the Leeds Institute of Cancer and Pathology research team, is funded by various cancer charities including The Brain Tumour Charity.

Dr Paul Brennan, from the University of Edinburgh, shares a round-up of his research with us.

In order to ensure that we fund only the highest quality research, we have formed two Scientific Advisory Boards (SABs) which are made up of internationally renowned scientific and medical experts that work in different areas of cancer research and social science.

Today we’re proud to announce a package of research initiatives totalling £4.3m.

“My own research lab studies the origins of cancer, particularly childhood brain tumours, and is seeking to develop completely new treatments of these devastating tumours.”

We are delighted to announce an overwhelmingly positive response to our latest appeal for research ideas, with a host of teams bidding to drive forward progress towards defeating brain tumours.